|
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer
|
5P50CA196530-04
|
$2,507,598
|
|
HERBST, ROY
|
YALE UNIVERSITY
|
|
WalkIT: Neighborhood walkability and moderation of adaptive walking interventions
|
5R01CA198915-04
|
$568,727
|
|
ADAMS, MARC
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Viral priming and targeting NK cells against solid tumor malignancies
|
5R35CA197292-04
|
$796,220
|
|
MILLER, JEFFREY
|
UNIVERSITY OF MINNESOTA
|
|
Validating Rapid Microfluidic Isolation of Personalized Aptamers for Monitoring Minimal Residual Disease in Multiple Myeloma
|
5R33CA196470-03
|
$386,051
|
|
LIN, QIAO
|
COLUMBIA UNIV NEW YORK MORNINGSIDE
|
|
Utility of RAS mimetics to block oncogenic signaling in colorectal cancer
|
1R21CA227963-01
|
$221,198
|
|
REDDY, E
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
Using Technology to Scale-Up an Occupational Sun Protection Policy Program
|
5R01CA210259-02
|
$667,691
|
|
BULLER, DAVID
|
KLEIN BUENDEL, INC.
|
|
Using Stat3 Signaling Profiles to Understand Chemotherapy Resistance in AML
|
5R01CA175026-05
|
$379,294
|
|
REDELL, MICHELE
|
BAYLOR COLLEGE OF MEDICINE
|
|
Urologic Oncology Research Training Grant
|
5T32CA082088-12
|
$254,589
|
$25,459
|
SCARDINO, PETER
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Urologic Oncology Branch Consult Core
|
ZID BC 011092
|
$1,932,712
|
$96,635
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Understanding the role of IDH in malignant gliomas
|
2R01CA154843-06A1
|
$384,750
|
|
MAHER, ELIZABETH
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Understanding the niche of minimal residual disease leukemia cells
|
2R01CA172896-06
|
$402,563
|
|
KIM, YONG-MI
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
Understanding Smokeless Tobacco and Electronic Cigarette Marketing
|
5R01CA141661-09
|
$559,091
|
|
LING, PAMELA
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Understanding EGF receptor activation by growth factors and oncogenic mutations
|
5R01CA198164-04
|
$520,420
|
|
LEMMON, MARK
|
YALE UNIVERSITY
|
|
Uncovering roles of polyunsaturated fatty acids in pancreatic cancer etiology
|
1K99CA218892-01A1
|
$120,472
|
|
WU, LANG
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Ultrabright Theranostic SERRS Nanoparticles for Gastrointestinal Endoscopy
|
1R01CA222836-01A1
|
$716,909
|
|
KIRCHER, MORITZ
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
UCLA Multifunctional Mesoporous Silica Nanoparticle Platform for Treatment of Pancreas Cancer
|
5U01CA198846-04
|
$459,169
|
|
NEL, ANDRE
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Ubiquilin1 regulates EMT and metastasis of human lung adenocarcinoma
|
5R01CA193220-04
|
$352,275
|
|
BEVERLY, LEVI
|
UNIVERSITY OF LOUISVILLE
|
|
Tumor-targeted inhibitors of stearoyl-CoA desaturase for the treatment of cancer.
|
1R01CA217333-01A1
|
$593,022
|
|
NIJHAWAN, DEEPAK
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Tumor-intrinsic oncogenic alterations and evasion of anti-tumor immunity
|
5R00CA204595-04
|
$249,000
|
|
SPRANGER, STEFANI
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Tumor-associated Physiological Changes Arising from Ras-induced Mitochondrial Fission
|
5F31CA196329-03
|
$31,856
|
|
NASCIMENTO, ALDO
|
UNIVERSITY OF VIRGINIA
|
|
Tumor Suppressor Localization and Function at the Peroxisome
|
5R01CA143811-10
|
$356,625
|
|
WALKER, CHERYL
|
BAYLOR COLLEGE OF MEDICINE
|
|
Tumor and host markers of clinical outcomes after MIBG therapy in neuroblastoma
|
1R01CA214912-01A1
|
$629,914
|
|
DUBOIS, STEVEN
|
DANA-FARBER CANCER INST
|
|
Tsc1/mTOR axis in immune homeostasis and tumorigenesis
|
5R01CA176624-05
|
$372,463
|
|
CHI, HONGBO
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Treatment of glioblastoma using chain-like nanoparticles
|
5U01CA198892-04
|
$561,808
|
|
KARATHANASIS, EFSTATHIOS
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Translational Molecular and Cellular Imaging Technologies for Prostate Tumor Pathology
|
5R33CA196458-03
|
$362,020
|
|
BHARGAVA, ROHIT
|
UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
|
|
Translating Molecular Diagnostics for Cervical Cancer Prevention into Practice
|
5R01CA190366-03
|
$521,245
|
|
GRAVITT, PATTI
|
GEORGE WASHINGTON UNIVERSITY
|
|
Transforming The Treatment of Tobacco Use in Health Care: Seizing The Potential of the Electronic Health Record to Deliver Comprehensive Chronic Care Treatment for Smoking
|
5R35CA197573-04
|
$873,630
|
|
FIORE, MICHAEL
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Transforming fluorescence lifetime imaging microscopy into a fast and simple platform for high-content molecular analysis
|
5R21CA206953-03
|
$221,650
|
|
HAUN, JERED
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
|
Transforming family dogs into a powerful and accessible model for human cancer
|
1R37CA218570-01A1
|
$687,174
|
|
KARLSSON, ELINOR
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
Transcriptional Regulation of the Androgen Receptor in Prostate Cancer
|
5K08CA218530-02
|
$177,056
|
|
TAKEDA, DAVID
|
DANA-FARBER CANCER INST
|
|
Training providers in CBT plus Hypnosis - an evidence-based fatigue intervention
|
5R25CA193098-04
|
$295,813
|
|
MONTGOMERY, GUY
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
Training Program in Translational Brain Tumor Research
|
5T32CA151022-09
|
$510,532
|
|
COSTELLO, JOSEPH
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Training Program in Free Radical and Radiation Biology
|
5T32CA078586-19
|
$247,107
|
|
SPITZ, DOUGLAS
|
UNIVERSITY OF IOWA
|
|
Training Program in Cancer Biology
|
5T32CA078207-19
|
$554,252
|
|
AARONSON, STUART
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
Training Program in Cancer Biology
|
5T32CA190216-03
|
$356,567
|
|
REYLAND, MARY
|
UNIVERSITY OF COLORADO DENVER
|
|
Training Program for Quantitative Population Sciences in Cancer
|
5R25CA134286-10
|
$120,932
|
|
KARAGAS, MARGARET
|
DARTMOUTH COLLEGE
|
|
Training Grant in Quantitative Sciences for Cancer Research
|
5T32CA009337-38
|
$532,403
|
|
PARMIGIANI, GIOVANNI
|
HARVARD SCHOOL OF PUBLIC HEALTH
|
|
Training Grant in Cancer Biology
|
5T32CA154274-08
|
$523,762
|
|
ANTALIS, TONI
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
Therapeutic Strategies for Patients With BRAF Mutant Colorectal Cancer
|
5R01CA187238-05
|
$332,000
|
|
HONG, DAVID
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
The thrombospondin1-TGF-beta axis in multiple myeloma
|
5R01CA175012-05
|
$598,327
|
|
MURPHY-ULLRICH, JOANNE
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
The Role of Viral and Cellular miRNAs in B-cell Lymphomagenesis
|
5R00CA175181-05
|
$219,120
|
|
SKALSKY, REBECCA
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
The role of TIM3 and CEACAM1 in anti-tumor function of human effector T cells
|
5R01CA219083-02
|
$368,288
|
|
MOON, EDMUND
|
UNIVERSITY OF PENNSYLVANIA
|
|
The role of The Xenopus Nonclassical MHC class I molecule XNC10 in Tumor Immunity
|
5F31CA192664-04
|
$42,497
|
|
BANACH, MAUREEN
|
UNIVERSITY OF ROCHESTER
|
|
The role of the PI3K pathway in immune resistance
|
5R01CA187076-05
|
$332,000
|
|
HWU, PATRICK
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
The role of PTEN feedback mechanism in cancer
|
5R01CA196740-03
|
$366,000
|
|
SONG, MIN SUP
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
The Role of post-translational activation of Myc in pancreatic cancer
|
3R01CA196228-04S1
|
$100,339
|
|
SEARS, ROSALIE
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
The role of PLAG1 in Wilms tumor formation
|
5K08CA207849-02
|
$156,645
|
|
CHEN, KENNETH
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
The role of p63 and p73 in cancer
|
5R01CA093853-09
|
$305,188
|
$76,297
|
MOLL, UTE
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
The Role of miR-29b in NK cell Development in Acute Myeloid Leukemia
|
1K22CA218466-01A1
|
$186,840
|
|
MUNDY-BOSSE, BETHANY
|
OHIO STATE UNIVERSITY
|
|
The Role of ITIH5 in Suppressing Pancreatic Cancer Metastasis
|
5F30CA216998-02
|
$29,724
|
|
YOUNG, ERIC
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
Total relevant funding to Testes for this search: $5,145,654
|